In order to address the issue of whether ER+ BRCA1 cancers are more akin to sporadic ER+ breast cancers than to ER- BRCA1 cancers, we performed a case-control analysis in which the pathologic features of these tumors were compared with those of a control group of ER+ sporadic breast cancers. The gene discussed is ESR1; the disease is cancer.